Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1450
-0.0020 (-1.36%)
Sep 5, 2025, 4:59 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 180.45 million as of September 5, 2025. Its market cap has decreased by -28.87% in one year.
Market Cap
180.45M
Enterprise Value
198.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 180.45M, a decrease of -76.48%. That is a compound annual growth rate of -44.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 180.45M | -22.63% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,592.75B |
| Coloplast | 137.26B |
| Genmab | 101.61B |
| Demant | 50.78B |
| ALK-Abelló | 44.72B |
| H. Lundbeck | 38.42B |
| Zealand Pharma | 31.27B |
| Ambu A/S | 25.47B |